NCT06650878 Desarda Tissue Technique vs Lichtenstein Technique for Primary Inguinal Hernia Repair
| NCT ID | NCT06650878 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Consorci Sanitari de l'Alt Penedès i Garraf |
| Condition | Inguinal Hernia Unilateral |
| Study Type | INTERVENTIONAL |
| Enrollment | 478 participants |
| Start Date | 2025-03-26 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 478 participants in total. It began in 2025-03-26 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate whether a surgical technique (Desarda) is superior to the commonly used surgical technique (Lichtenstein) in inguinal hernia repair concerning the occurrence of postoperative complications. The Lichtenstein technique involves the use of a mesh, while the Desarda technique does not.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with primary inguinal hernia. * Body mass index below 31 * Indication for inguinal hernia repair via anterior approach, either as outpatient surgery (CMA) or elective admission. * Legal capacity to provide informed consent. Exclusion Criteria: * Patients with a weak, thin, or divided external oblique aponeurosis. * Participants diagnosed with any of the following conditions: * Ongoing oncological disease * Cirrhotic patients classified as Child B or higher * Women who have previously undergone a cesarean section * Cognitive or affective conditions that limit the ability to cooperate with the study procedures
Contact & Investigator
Javier Errando, MD
PRINCIPAL INVESTIGATOR
CSAPG
Frequently Asked Questions
Who can join the NCT06650878 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Inguinal Hernia Unilateral. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06650878 currently recruiting?
Yes, NCT06650878 is actively recruiting participants. Contact the research team at jerrando@csapg.cat for enrollment information.
Where is the NCT06650878 trial being conducted?
This trial is being conducted at Sant Pere de Ribes, Spain.
Who is sponsoring the NCT06650878 clinical trial?
NCT06650878 is sponsored by Consorci Sanitari de l'Alt Penedès i Garraf. The principal investigator is Javier Errando, MD at CSAPG. The trial plans to enroll 478 participants.